CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• OP. Inc. Y/Y Annual
Kiromic Biopharma Inc   (KRBP)
Other Ticker:  
 
 

KRBP's Operating Income Growth by Quarter and Year

Kiromic Biopharma Inc 's Operating Income results by quarter and year




KRBP Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -5.32 -6.92 -10.66 2.42
III Quarter September -5.55 -8.40 -6.14 -2.42
II Quarter June -4.29 -8.43 -4.97 0.00
I Quarter March -4.78 -7.37 -3.96 0.00
FY   -19.94 -31.12 -25.73 0.00



KRBP Operating Income fourth quarter 2023 Y/Y Growth Comment
Kiromic Biopharma Inc in the fourth quarter 2023 recorded Operating Loss of $ -5.32 millions.

According to the results reported in the fourth quarter 2023, Kiromic Biopharma Inc achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Kiromic Biopharma Inc ' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2023.

Explain Operating Income growth


KRBP Operating Income ( Y/Y Growth %) 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kiromic Biopharma Inc 's fourth quarter 2023 Operating Income $ -5.32 millions KRBP's Income Statement
Kiromic Biopharma Inc 's fourth quarter 2022 Operating Income $ -6.92 millions Quarterly KRBP's Income Statement
New: More KRBP's historic Operating Income Growth >>


KRBP Operating Income (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -


Compare KRBP Profitability >> Back to KRBP Growth rate Comparisons >>


Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Kiromic Biopharma Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KRBP's IV. Quarter Q/Q Operating Income Comment
Although Kiromic Biopharma Inc in the IV. Quarter 2023 admitted Operating Loss of $ -5.32 millions, some analyst mentioned, that those numbers show improvement relative to the -5.55 millions in the third quarter.

Within Biotechnology & Pharmaceuticals industry Kiromic Biopharma Inc achieved highest sequential Operating Income growth. While Kiromic Biopharma Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KRBP's IV. Quarter Q/Q Operating Income Comment
Even if Kiromic Biopharma Inc in the IV. Quarter 2023 showed Operating Loss of $ -5.32 millions, management mentioned, that current results show slight up side compare to the -5.55 millions in the third quarter.

Within Biotechnology & Pharmaceuticals industry Kiromic Biopharma Inc achieved highest sequential Operating Income growth. While Kiromic Biopharma Inc 's Operating Income growth quarter on quarter, overall rank is .


Kiromic Biopharma Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ -19.94 $ -21.54 $ -24.39 $ -28.53 $ -31.11
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #

New: More KRBP's historic Operating Income Growth >>



Cumulative Operating Income growth Comment


Kiromic Biopharma Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Kiromic Biopharma Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
KRBP's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for KRBP's Competitors
Operating Income Growth for Kiromic Biopharma Inc 's Suppliers
Operating Income Growth for KRBP's Customers

You may also want to know
KRBP's Annual Growth Rates KRBP's Profitability Ratios KRBP's Asset Turnover Ratio KRBP's Dividend Growth
KRBP's Roe KRBP's Valuation Ratios KRBP's Financial Strength Ratios KRBP's Dividend Payout Ratio
KRBP's Roa KRBP's Inventory Turnover Ratio KRBP's Growth Rates KRBP's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Cadre Holdings Inc -0.36%$ -0.362 millions
Prestige Consumer Healthcare Inc -0.40%$ -0.404 millions
Phibro Animal Health Corporation-0.90%$ -0.903 millions
Inmode Ltd -1.11%$ -1.109 millions
Resmed Inc -1.82%$ -1.820 millions
Essa Pharma inc -3.45%$ -3.446 millions
Bausch and Lomb Corp-3.92%$ -3.922 millions
National Research Corporation-4.35%$ -4.346 millions
Vertex Pharmaceuticals Inc-4.35%$ -4.354 millions
Icecure Medical Ltd -6.95%$ -6.948 millions
Fresenius Medical Care Ag-9.41%$ -9.414 millions
Edwards Lifesciences Corporation-10.65%$ -10.652 millions
Regeneron Pharmaceuticals Inc -15.16%$ -15.164 millions
Harmony Biosciences Holdings inc -15.58%$ -15.578 millions
Scisparc Ltd -17.76%$ -17.763 millions
Charles River Laboratories International inc -18.86%$ -18.856 millions
Biogen Inc -19.42%$ -19.417 millions
Mettler toledo International Inc -19.91%$ -19.915 millions
Bristol myers Squibb Company-20.65%$ -20.646 millions
Qiagen N v -22.87%$ -22.866 millions
Baxter International Inc -22.95%$ -22.946 millions
Artivion Inc -23.20%$ -23.196 millions
Bio rad Laboratories Inc -24.46%$ -24.460 millions
Hologic Inc-24.47%$ -24.466 millions
Becton Dickinson And Company-24.96%$ -24.957 millions
Mesoblast Ltd-25.69%$ -25.686 millions
Sanofi-26.10%$ -26.098 millions
Amedisys Inc -26.45%$ -26.448 millions
Avantor Inc -27.20%$ -27.204 millions
Gilead Sciences Inc -28.89%$ -28.893 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com